• Oxytetracycline,Atava Tech Ltd,Oxytetracycline | Broad-Spectrum Veterinary Antibiotic Powder
  • Oxytetracycline,Atava Tech Ltd,Oxytetracycline | Broad-Spectrum Veterinary Antibiotic Powder

Oxytetracycline

Oxytetracycline (OTC) is a tetracycline antibiotic for cattle, swine, poultry and aquaculture. Treats pneumonia, enteritis and bacterial infections. High purity, bulk supply.
  • Oxytetracycline,Atava Tech Ltd,Oxytetracycline | Broad-Spectrum Veterinary Antibiotic Powder

Description

Technical Introduction to Oxytetracycline Intermediate

1. Basic Definition

Oxytetracycline intermediate is a key chemical precursor in the synthesis of oxytetracycline active pharmaceutical ingredients (APIs). Belonging to the tetracycline-class antibiotic intermediates, it is not directly applicable for veterinary clinical use. Instead, it serves as a critical raw material for producing final oxytetracycline formulations (e.g., soluble powders, premixes, injections) through further refinement, purification, and salification processes. Its quality directly determines the purity, potency, and safety of downstream finished veterinary drugs.

2. Physicochemical Properties

Property Details
Chemical Category Tetracycline-class antibiotic intermediate
Core Chemical Structure Tetracycline nucleus (four fused benzene rings) with active functional groups (hydroxyl, amino, ketone)
Molecular Formula (Typical) C₂₂H₂₄N₂O₉ (for oxytetracycline base intermediate)
Cas No. 79-57-2
Appearance Light yellow to yellow crystalline powder
Solubility Slightly soluble in water; easily soluble in dilute acids, dilute alkalis, methanol, and ethanol
Stability Light and heat sensitive; prone to decomposition under high temperature or direct sunlight
Storage Condition Store in a sealed, light-proof container at 2-8℃

3. Key Quality Specifications

Oxytetracycline intermediate follows customized quality standards set by downstream API manufacturers and importing country regulations.

4. Application Fields

Oxytetracycline intermediate is exclusively used as a raw material for antibiotic production with no other industrial applications. Its specific uses include:
  1. Synthesis of Veterinary Oxytetracycline APIs: After refinement and salification (e.g., oxytetracycline hydrochloride), it is processed into various veterinary formulations for treating bacterial infections in livestock, poultry, and aquatic products.
  2. Production of Tetracycline Derivatives: Some high-purity intermediates can be modified structurally to synthesize advanced tetracycline antibiotics (e.g., doxycycline, minocycline).
Critical Note: This intermediate is not allowed to be directly added to feed or used for animal treatment and must be strictly managed separately from finished veterinary drugs.

5. Key Considerations for Foreign Trade Export

5.1 Product Classification & HS Code

  • Recommended HS Code: 29413000 (Tetracycline-class antibiotic derivatives) or 29339900 (Other nitrogen-containing heterocyclic compounds)
  • Action Requirement: Confirm the exact HS code with local customs authorities based on the intermediate’s specific structure, purity, and intended use to avoid declaration errors.

5.2 Compliance Documents Preparation

  • Certificate of Analysis (CoA): Must include test results for purity, related substances, heavy metals, and residual solvents.
  • Safety Data Sheet (SDS): Compliant with the importing country’s standards (e.g., EU CLP, US OSHA) to specify transportation, storage, and safety precautions.
  • Usage Declaration: Clearly state "For oxytetracycline API production only; not for direct veterinary or feed use".

5.3 Transportation & Storage Requirements

  • Transportation: Classified as ordinary chemicals (non-toxic, non-precursor; subject to SDS confirmation). Use light-proof, sealed packaging and avoid high temperature, humidity, and direct sunlight during transit.
  • Storage Period: 6-12 months under recommended storage conditions.

5.4 Importing Country Compliance Key Points

  • EU Market: Comply with REACH regulation (registration required for annual output ≥ 1 ton); provide SDS and CoA. If used for veterinary drug production, the manufacturing facility must meet EU GMP standards.
  • US Market: Complete TSCA (Toxic Substances Control Act) filing with EPA; downstream customers may conduct DMF (Drug Master File) filing as needed.
  • Emerging Markets (Southeast Asia, South America): Confirm that the importer holds a valid chemical intermediate import license; provide labels and documents in the local official language.
  • Precursor Chemical Control: Verify if the intermediate is listed in the importing country’s precursor chemical directory to apply for additional import/export permits if required.